Cargando…
Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis
Lung adenocarcinoma (LUAD), which accounts for 60% of non-small-cell lung cancers, is poorly diagnosed and has a low average 5-year survival rate (approximately 20%). It remains the leading cause of cancer-related deaths worldwide. Studies on long noncoding RNAs (lncRNAs) in LUAD-related competing e...
Autores principales: | Hou, Jili, Yao, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822677/ https://www.ncbi.nlm.nih.gov/pubmed/33511215 http://dx.doi.org/10.1155/2021/8859996 |
Ejemplares similares
-
Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021) -
Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis
por: Guo, Pengyi, et al.
Publicado: (2022) -
Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics
por: Cai, Kaier, et al.
Publicado: (2023) -
Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples
por: Dong, Siyuan, et al.
Publicado: (2020) -
Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis
por: Li, Zhaodong, et al.
Publicado: (2021)